Usage Information

A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter.
S Ghosh, E R Hauser, V L Magnuson, T Valle, D S Ally, Z E Karanjawala, J B Rayman, J I Knapp, A Musick, J Tannenbaum, C Te, W Eldridge, S Shapiro, T Musick, C Martin, A So, A Witt, J B Harvan, R M Watanabe, W Hagopian, J Eriksson, S J Nylund, K Kohtamaki, E Tuomilehto-Wolf, M Boehnke
S Ghosh, E R Hauser, V L Magnuson, T Valle, D S Ally, Z E Karanjawala, J B Rayman, J I Knapp, A Musick, J Tannenbaum, C Te, W Eldridge, S Shapiro, T Musick, C Martin, A So, A Witt, J B Harvan, R M Watanabe, W Hagopian, J Eriksson, S J Nylund, K Kohtamaki, E Tuomilehto-Wolf, M Boehnke
View: Text | PDF
Research Article

A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter.

Abstract

In the first reported positive result from a genome scan for non-insulin-dependent diabetes mellitus (NIDDM), Hanis et al. found significant evidence of linkage for NIDDM on chromosome 2q37 and named the putative disease locus NIDDM1 (Hanis et al. 1996. Nat. Genet. 13:161-166). Their total sample was comprised of 440 Mexican-American affected sib-pairs from 246 sibships. The strongest evidence for linkage was at marker D2S125 and best estimates of lambdas (risk to siblings of probands/population prevalence) using this marker were 1.37 under an additive model and 1.36 under a multiplicative model. We examined this chromosomal region using linkage analysis in a Finnish sample comprised of 709 affected sib-pairs from 472 sibships. We excluded this region in our sample (multipoint logarithm of odds score /= 1.37. We discuss possible reasons why linkage to 2q37 was not found and conclude that this region is unlikely to be playing a major role in NIDDM susceptibility in the Finnish Caucasian population.

Authors

S Ghosh, E R Hauser, V L Magnuson, T Valle, D S Ally, Z E Karanjawala, J B Rayman, J I Knapp, A Musick, J Tannenbaum, C Te, W Eldridge, S Shapiro, T Musick, C Martin, A So, A Witt, J B Harvan, R M Watanabe, W Hagopian, J Eriksson, S J Nylund, K Kohtamaki, E Tuomilehto-Wolf, M Boehnke

×

Usage data is cumulative from December 2024 through December 2025.

Usage JCI PMC
Text version 412 8
PDF 77 3
Citation downloads 80 0
Totals 569 11
Total Views 580
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement